Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D
Release Date:
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.
Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D